These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
426 related articles for article (PubMed ID: 29478415)
1. Development and evaluation of novel tumor-targeting paclitaxel-loaded nano-carriers for ovarian cancer treatment: in vitro and in vivo. Yao S; Li L; Su XT; Wang K; Lu ZJ; Yuan CZ; Feng JB; Yan S; Kong BH; Song K J Exp Clin Cancer Res; 2018 Feb; 37(1):29. PubMed ID: 29478415 [TBL] [Abstract][Full Text] [Related]
2. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo. Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391 [TBL] [Abstract][Full Text] [Related]
3. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123 [TBL] [Abstract][Full Text] [Related]
4. In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle. Rezazadeh M; Emami J; Hasanzadeh F; Sadeghi H; Minaiyan M; Mostafavi A; Rostami M; Lavasanifar A Drug Deliv; 2016 Jun; 23(5):1707-17. PubMed ID: 25188785 [TBL] [Abstract][Full Text] [Related]
5. Radioluminescent nanoparticles for radiation-controlled release of drugs. Misra R; Sarkar K; Lee J; Pizzuti VJ; Lee DS; Currie MP; Torregrosa-Allen SE; Long DE; Durm GA; Langer MP; Elzey BD; Won YY J Control Release; 2019 Jun; 303():237-252. PubMed ID: 31026550 [TBL] [Abstract][Full Text] [Related]
6. Novel Nano-Therapeutic Approach Actively Targets Human Ovarian Cancer Stem Cells after Xenograft into Nude Mice. Abou-ElNaga A; Mutawa G; El-Sherbiny IM; Abd-ElGhaffar H; Allam AA; Ajarem J; Mousa SA Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417924 [TBL] [Abstract][Full Text] [Related]
7. Folic acid-coupled nano-paclitaxel liposome reverses drug resistance in SKOV3/TAX ovarian cancer cells. Tong L; Chen W; Wu J; Li H Anticancer Drugs; 2014 Mar; 25(3):244-54. PubMed ID: 24275314 [TBL] [Abstract][Full Text] [Related]
8. Folic Acid and Poly(ethylene glycol) Decorated Paclitaxel Nanocrystals Exhibit Enhanced Stability and Breast Cancer-Targeting Capability. Zhao J; Du J; Wang J; An N; Zhou K; Hu X; Dong Z; Liu Y ACS Appl Mater Interfaces; 2021 Mar; 13(12):14577-14586. PubMed ID: 33728919 [TBL] [Abstract][Full Text] [Related]
9. CXCL12/CXCR4 Axis-Targeted Dual-Functional Nano-Drug Delivery System Against Ovarian Cancer. Xue J; Li R; Gao D; Chen F; Xie H Int J Nanomedicine; 2020; 15():5701-5718. PubMed ID: 32848392 [TBL] [Abstract][Full Text] [Related]
10. Folate-receptor-targeted laser-activable poly(lactide- Liu F; Chen Y; Li Y; Guo Y; Cao Y; Li P; Wang Z; Gong Y; Ran H Int J Nanomedicine; 2018; 13():5139-5158. PubMed ID: 30233177 [TBL] [Abstract][Full Text] [Related]
11. D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery. Wu Y; Chu Q; Tan S; Zhuang X; Bao Y; Wu T; Zhang Z Int J Nanomedicine; 2015; 10():5219-35. PubMed ID: 26316751 [TBL] [Abstract][Full Text] [Related]
12. Tumor-targeted paclitaxel-loaded folate conjugated poly(ethylene glycol)-poly(L-lactide) microparticles produced by supercritical fluid technology. Huang X; Zhang Y; Yin G; Pu X; Liao X; Huang Z; Chen X; Yao Y J Mater Sci Mater Med; 2015 Feb; 26(2):95. PubMed ID: 25649516 [TBL] [Abstract][Full Text] [Related]
13. Hypocrellin B-loaded, folate-conjugated polymeric micelle for intraperitoneal targeting of ovarian cancer in vitro and in vivo. Li J; Yao S; Wang K; Lu Z; Su X; Li L; Yuan C; Feng J; Yan S; Kong B; Song K Cancer Sci; 2018 Jun; 109(6):1958-1969. PubMed ID: 29617063 [TBL] [Abstract][Full Text] [Related]
14. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer. He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524 [TBL] [Abstract][Full Text] [Related]
15. Estrone-Conjugated PEGylated Liposome Co-Loaded Paclitaxel and Carboplatin Improve Anti-Tumor Efficacy in Ovarian Cancer and Reduce Acute Toxicity of Chemo-Drugs. Tang H; Xie Y; Zhu M; Jia J; Liu R; Shen Y; Zheng Y; Guo X; Miao D; Pei J Int J Nanomedicine; 2022; 17():3013-3041. PubMed ID: 35836838 [TBL] [Abstract][Full Text] [Related]
16. Development and evaluation of a novel TPGS-mediated paclitaxel-loaded PLGA-mPEG nanoparticle for the treatment of ovarian cancer. Lv W; Cheng L; Li B Chem Pharm Bull (Tokyo); 2015; 63(2):68-74. PubMed ID: 25451039 [TBL] [Abstract][Full Text] [Related]
17. Optimization, Characterization and in vivo Evaluation of Paclitaxel-Loaded Folate-Conjugated Superparamagnetic Iron Oxide Nanoparticles. Gui G; Fan Z; Ning Y; Yuan C; Zhang B; Xu Q Int J Nanomedicine; 2021; 16():2283-2295. PubMed ID: 33776433 [TBL] [Abstract][Full Text] [Related]
18. Co-delivery of paclitaxel (PTX) and docosahexaenoic acid (DHA) by targeting lipid nanoemulsions for cancer therapy. Li B; Tan T; Chu W; Zhang Y; Ye Y; Wang S; Qin Y; Tang J; Cao X Drug Deliv; 2022 Dec; 29(1):75-88. PubMed ID: 34964421 [TBL] [Abstract][Full Text] [Related]
19. "OA02" peptide facilitates the precise targeting of paclitaxel-loaded micellar nanoparticles to ovarian cancer in vivo. Xiao K; Li Y; Lee JS; Gonik AM; Dong T; Fung G; Sanchez E; Xing L; Cheng HR; Luo J; Lam KS Cancer Res; 2012 Apr; 72(8):2100-10. PubMed ID: 22396491 [TBL] [Abstract][Full Text] [Related]
20. Paclitaxel-loaded hyaluronan solid nanoemulsions for enhanced treatment efficacy in ovarian cancer. Kim JE; Park YJ Int J Nanomedicine; 2017; 12():645-658. PubMed ID: 28176896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]